Cannabidiol, otherwise known as CBD, hits the headlines, and is eagerly awaited by consumers.
This substance is currently not authorized in France in food, it can not be marketed either as food, or as a food supplement to date.
CBD comes mainly from hemp inflorescences. Even if CBD is no longer considered as “narcotic” according to the judgment of the European Court of Justice of November 19, 2020, the marketing of hemp remains limited for the moment only to fibers and seeds according to the French decree of 22 August 1990. This 1990 decree must soon be revised to normally include all parts of the hemp plants.
Cannabis sativa L. extracts and derivative products containing CBD are considered to be new foods, their history of consumption and safety have not been demonstrated. Thus, according to Regulation (EU) 2015/2283, it is prohibited to market foods or food supplements containing CBD throughout the European Union, as long as it is not specifically authorized under the Novel Food procedure. Numerous applications for authorization of CBD under the Novel Food procedure have been submitted, so it will be necessary to wait for these applications to be accepted to put CBD on the market.
News shows us that regulations are evolving. The regulatory control of the Pierre Caron laboratory and its permanent monitoring allow us a detailed analysis of this subject. This will then allow us to be ready when CBD can be authorized as a food supplement in France.
Thanks to its privileged relationships with suppliers, our R&D team has already identified sources and is ready to develop future CBD-based food supplements when regulations allow.